Berberine Chloride is an Alphavirus Inhibitor That Targets Nucleocapsid Assembly

ABSTRACT Alphaviruses are enveloped positive-sense RNA viruses that can cause serious human illnesses such as polyarthritis and encephalitis. Despite their widespread distribution and medical importance, there are no licensed vaccines or antivirals to combat alphavirus infections. Berberine chloride...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Judy J. Wan, Rebecca S. Brown, Margaret Kielian
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2020
Materias:
Acceso en línea:https://doaj.org/article/f23789612e504d87af66ef62aa096096
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f23789612e504d87af66ef62aa096096
record_format dspace
spelling oai:doaj.org-article:f23789612e504d87af66ef62aa0960962021-11-15T15:56:47ZBerberine Chloride is an Alphavirus Inhibitor That Targets Nucleocapsid Assembly10.1128/mBio.01382-202150-7511https://doaj.org/article/f23789612e504d87af66ef62aa0960962020-06-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01382-20https://doaj.org/toc/2150-7511ABSTRACT Alphaviruses are enveloped positive-sense RNA viruses that can cause serious human illnesses such as polyarthritis and encephalitis. Despite their widespread distribution and medical importance, there are no licensed vaccines or antivirals to combat alphavirus infections. Berberine chloride (BBC) is a pan-alphavirus inhibitor that was previously identified in a replicon-based small-molecule screen. This work showed that BBC inhibits alphavirus replication but also suggested that BBC might have additional effects later in the viral life cycle. Here, we show that BBC has late effects that target the virus nucleocapsid (NC) core. Infected cells treated with BBC late in infection were unable to form stable cytoplasmic NCs or assembly intermediates, as assayed by gradient sedimentation. In vitro studies with recombinant capsid protein (Cp) and purified genomic RNA (gRNA) showed that BBC perturbs core-like particle formation and potentially traps the assembly process in intermediate states. Particles produced from BBC-treated cells were less infectious, despite efficient particle production and only minor decreases in genome packaging. In addition, BBC treatment of free virus particles strongly decreased alphavirus infectivity. In contrast, the infectivity of the negative-sense RNA virus vesicular stomatitis virus was resistant to BBC treatment of infected cells or free virus. Together, our data indicate that BBC alters alphavirus Cp-gRNA interactions and oligomerization and suggest that this may cause defects in NC assembly and in disassembly during subsequent virus entry. Thus, BBC may be considered a novel alphavirus NC assembly inhibitor. IMPORTANCE The alphavirus chikungunya virus (CHIKV) is an example of an emerging human pathogen with increased and rapid global spread. Although an acute CHIKV infection is rarely fatal, many patients suffer from debilitating chronic arthralgia for years. Antivirals against chikungunya and other alphaviruses have been identified in vitro, but to date none have been shown to be efficacious and have been licensed for human use. Here, we investigated a small molecule, berberine chloride (BBC), and showed that it inhibited infectious virus production by several alphaviruses including CHIKV. BBC acted on a late step in the alphavirus exit pathway, namely the formation of the nucleocapsid containing the infectious viral RNA. Better understanding of nucleocapsid formation and its inhibition by BBC will provide important information on the mechanisms of infectious alphavirus production and may enable their future targeting in antiviral strategies.Judy J. WanRebecca S. BrownMargaret KielianAmerican Society for MicrobiologyarticleberberineRNA packagingalphavirusantiviral inhibitornucleocapsid assemblyMicrobiologyQR1-502ENmBio, Vol 11, Iss 3 (2020)
institution DOAJ
collection DOAJ
language EN
topic berberine
RNA packaging
alphavirus
antiviral inhibitor
nucleocapsid assembly
Microbiology
QR1-502
spellingShingle berberine
RNA packaging
alphavirus
antiviral inhibitor
nucleocapsid assembly
Microbiology
QR1-502
Judy J. Wan
Rebecca S. Brown
Margaret Kielian
Berberine Chloride is an Alphavirus Inhibitor That Targets Nucleocapsid Assembly
description ABSTRACT Alphaviruses are enveloped positive-sense RNA viruses that can cause serious human illnesses such as polyarthritis and encephalitis. Despite their widespread distribution and medical importance, there are no licensed vaccines or antivirals to combat alphavirus infections. Berberine chloride (BBC) is a pan-alphavirus inhibitor that was previously identified in a replicon-based small-molecule screen. This work showed that BBC inhibits alphavirus replication but also suggested that BBC might have additional effects later in the viral life cycle. Here, we show that BBC has late effects that target the virus nucleocapsid (NC) core. Infected cells treated with BBC late in infection were unable to form stable cytoplasmic NCs or assembly intermediates, as assayed by gradient sedimentation. In vitro studies with recombinant capsid protein (Cp) and purified genomic RNA (gRNA) showed that BBC perturbs core-like particle formation and potentially traps the assembly process in intermediate states. Particles produced from BBC-treated cells were less infectious, despite efficient particle production and only minor decreases in genome packaging. In addition, BBC treatment of free virus particles strongly decreased alphavirus infectivity. In contrast, the infectivity of the negative-sense RNA virus vesicular stomatitis virus was resistant to BBC treatment of infected cells or free virus. Together, our data indicate that BBC alters alphavirus Cp-gRNA interactions and oligomerization and suggest that this may cause defects in NC assembly and in disassembly during subsequent virus entry. Thus, BBC may be considered a novel alphavirus NC assembly inhibitor. IMPORTANCE The alphavirus chikungunya virus (CHIKV) is an example of an emerging human pathogen with increased and rapid global spread. Although an acute CHIKV infection is rarely fatal, many patients suffer from debilitating chronic arthralgia for years. Antivirals against chikungunya and other alphaviruses have been identified in vitro, but to date none have been shown to be efficacious and have been licensed for human use. Here, we investigated a small molecule, berberine chloride (BBC), and showed that it inhibited infectious virus production by several alphaviruses including CHIKV. BBC acted on a late step in the alphavirus exit pathway, namely the formation of the nucleocapsid containing the infectious viral RNA. Better understanding of nucleocapsid formation and its inhibition by BBC will provide important information on the mechanisms of infectious alphavirus production and may enable their future targeting in antiviral strategies.
format article
author Judy J. Wan
Rebecca S. Brown
Margaret Kielian
author_facet Judy J. Wan
Rebecca S. Brown
Margaret Kielian
author_sort Judy J. Wan
title Berberine Chloride is an Alphavirus Inhibitor That Targets Nucleocapsid Assembly
title_short Berberine Chloride is an Alphavirus Inhibitor That Targets Nucleocapsid Assembly
title_full Berberine Chloride is an Alphavirus Inhibitor That Targets Nucleocapsid Assembly
title_fullStr Berberine Chloride is an Alphavirus Inhibitor That Targets Nucleocapsid Assembly
title_full_unstemmed Berberine Chloride is an Alphavirus Inhibitor That Targets Nucleocapsid Assembly
title_sort berberine chloride is an alphavirus inhibitor that targets nucleocapsid assembly
publisher American Society for Microbiology
publishDate 2020
url https://doaj.org/article/f23789612e504d87af66ef62aa096096
work_keys_str_mv AT judyjwan berberinechlorideisanalphavirusinhibitorthattargetsnucleocapsidassembly
AT rebeccasbrown berberinechlorideisanalphavirusinhibitorthattargetsnucleocapsidassembly
AT margaretkielian berberinechlorideisanalphavirusinhibitorthattargetsnucleocapsidassembly
_version_ 1718427128005918720